BioHealth News Archive
Jonathan DeCarlo Named Chief Financial Officer at Emmes
ROCKVILLE, Md., Sept. 1, 2020 /PRNewswire/ -- Emmes today announced that Jonathan DeCarlo has been promoted to chief financial officer. DeCarlo, who has served as…
Read More
Johns Hopkins University Giving Wellness Kits To Undergrads To Protect Against COVID-19 – CBS Baltimore
BALTIMORE (WJZ) — As the fall semester begins, Johns Hopkins University wants to make sure its students are protected. They are giving out wellness…
Read More
ITI Announces Publication of Results from 3 ATTAC Studies of CMV-Specific Dendritic Cell Vaccines for the Treatment of GBM – Immunomic Therapeutics
ROCKVILLE, Md. & SAN DIEGO–(BUSINESS WIRE)–Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, announced today…
Read More
5th Annual BioHealth Capital Region (BHCR) Crab Trap Competition
Don't miss your change to be named the BioHealth Startup with the Most Commectial Potential at the BHCR Forum, win $10,000 and more! …
Read More
Unique Team-Building and Promotion for your BioHealth Company: FRAXA Biotech Games™ for Research – Register Now. Games Begin This Thursday Sept. 10th
Are you seeking an opportunity to engage your firm in a fun community-building activity? Register one or more teams for the FRAXA Biotech Games. …
Read More
Cartesian Therapeutics Initiates Clinical Trial of First RNA-Engineered Cell Therapy for Acute Respiratory Distress Syndrome and COVID-19 – Cartesian
Gaithersburg, MD, September 1, 2020 – Cartesian Therapeutics, a fully integrated, clinical-stage biopharmaceutical company developing cell and gene therapies for cancer, autoimmune diseases and…
Read MoreOxiWear rushes to get wearable oxygen monitor to Covid-19 patients – Washington Business Journal
OxiWear's own founder is a user herself of its oxygen monitor for patients with severe pulmonary hypertension. Image: Shavini Fernando is founder and CEO…
Read More
Economic Alliance of Greater Baltimore (EAGB), President and CEO, Michele L. Whelley, Joins Rich Bendis on BioTalk
Economic Alliance of Greater Baltimore (EAGB), President and CEO, Michele L. Whelley, joins BioTalk to discuss her career, the economic development environment in Baltimore,…
Read More
Novavax and Canada Reach Agreement in Principle to Acquire Novavax’ COVID-19 Vaccine | Novavax Inc. – IR Site
GAITHERSBURG, Md., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases,…
Read More
Hampton Roads accelerator program goes virtual amid pandemic – The Virginian-Pilot – Inside Business
Imagine being able to use science to choose the right music for an advertising campaign or being able to order food and groceries on…
Read More
REGENXBIO Announces FDA Clearance of IND for Phase II Trial of RGX-314 for the Treatment of Diabetic Retinopathy Using Suprachoroidal Delivery | BioSpace
ROCKVILLE, Md., Aug. 25, 2020 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential…
Read More
Arcellx Announces EvansMDS Grant Awarded for Collaboration with Johns Hopkins and University of Colorado Researchers to Support Development of Arcellx ARC-sparX Platform Candidate ACLX-002
GAITHERSBURG, Md., Aug. 24, 2020 (GLOBE NEWSWIRE) -- Arcellx today announced the award of an EvansMDS Discovery Research Grant to Johns Hopkins University to…
Read MoreCrisis innovators: How 5 local companies are addressing the pandemic head-on – DC Inno
Coronavirus made 2020 the year of the pivot. But the D.C.-area ventures having real, direct impact on the Covid-19 crisis have done more than…
Read More
Catalent to make drug substance for AstraZeneca’s COVID-19 vaccine candidate – Reuters
(Reuters) - Catalent Inc said on Monday its Maryland facility would make the drug substance used in the COVID-19 vaccine being developed by AstraZeneca…
Read More
Alexandria Real Estate Equities pays $590.4 million for huge portion of Parmer RTP – Triangle Business Journal
A huge portion of a campus in Research Triangle Park has been sold in a deal that tops $590 million. {iframe}https://www.bizjournals.com/triangle/news/2020/08/25/parmer-rtp-sells-253-acres-in-590-million.html{/iframe}
Read More